Woodline Partners’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-86,131	Closed	-$973K	–	809
2022 Q2	$973K	Buy	86,131 +3,765	+5%	+$42.5K	0.02%	519
2022 Q1	$2.46M	Buy	+82,366	New	+$2.46M	0.04%	350